RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bindong Liu to Diabetes Mellitus, Experimental

This is a "connection" page, showing publications Bindong Liu has written about Diabetes Mellitus, Experimental.
Connection Strength

1.133
  1. Tang RN, Lv LL, Zhang JD, Dai HY, Li Q, Zheng M, Ni J, Ma KL, Liu BC. Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats. Int J Cardiol. 2013 Jan 10; 162(2):92-9.
    View in: PubMed
    Score: 0.360
  2. Dai HY, Zheng M, Tang RN, Ni J, Ma KL, Li Q, Liu BC. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. Am J Med Sci. 2011 Mar; 341(3):207-14.
    View in: PubMed
    Score: 0.352
  3. Liu BC, Chen L, Sun J, Huang HQ, Ma KL, Liu H, Liu DG, Zhang XL. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells. Nephron Exp Nephrol. 2006; 103(1):e16-26.
    View in: PubMed
    Score: 0.245
  4. Lu J, Chen PP, Zhang JX, Li XQ, Wang GH, Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, Liu WT, Ruan XZ, Liu BC, Ma KL. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKa activity. Theranostics. 2021; 11(10):4728-4742.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support